Research output per year
Research output per year
Search results
-
2023
Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors (Journal of Experimental & Clinical Cancer Research, (2023), 42, 1, (76), 10.1186/s13046-023-02649-6)
Cole, C. B., Morelli, M. P., Fantini, M., Miettinen, M., Fetsch, P., Peer, C., Figg, W. D., Yin, T., Houston, N., McCoy, A., Lipkowitz, S., Zimmer, A., Lee, J. M., Pavelova, M., Villanueva, E. N., Trewhitt, K., Solarz, B. B., Fergusson, M., Mavroukakis, S. A. & Zaki, A. & 3 others, , Dec 2023, In: Journal of Experimental and Clinical Cancer Research. 42, 1, 102.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Scopus citations -
2008
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells (Journal of Cellular Physiology (2008) 216, (698-707) DOI: 10.1002/jcp.21444)
Cascone, T., Morelli, M. P., Morgillo, F., Kim, W. Y., Rodolico, G., Pepe, S., Tortora, G., Berrino, L., Lee, H. Y., Heymach, J. V. & Ciardiello, F., Oct 2008, In: Journal of Cellular Physiology. 217, 1, p. 290 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access